Original paper

SCO‐792, an enteropeptidase inhibitor, improves disease status of diabetes and obesity in mice

Volume: 21, Issue: 10, Pages: 2228 - 2239
Published: Jul 2, 2019
Abstract
Aims Enteropeptidase is a serine protease localized on the duodenal brush border that catalyzes the conversion of inactive trypsinogen into active trypsin, thereby regulating protein breakdown in the gut. We evaluated the effects of SCO‐792, a novel enteropeptidase inhibitor, in mice. Materials and methods In vivo inhibition of enteropeptidase was evaluated via an oral protein challenge. Pharmacological effects were evaluated in normal mice, in...
Paper Details
Title
SCO‐792, an enteropeptidase inhibitor, improves disease status of diabetes and obesity in mice
Published Date
Jul 2, 2019
Volume
21
Issue
10
Pages
2228 - 2239
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.